查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612592

比沙可啶市場：按劑量類型、應用、分銷管道 - 全球預測 2025-2030

Bisacodyl Market by Administration Type (Oral Medications, Suppository Medications), Application (Constipation, Neurogenic Bowl Dysfunction), Distribution Channels - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年比沙可啶市值為12.8億美元，預計到2024年將達到13.5億美元，複合年成長率為6.49%，預計到2030年將達到19.9億美元。

比沙可啶是一種刺激性瀉藥，主要用於刺激腸蠕動和治療便秘。在市場研究中，其範圍涵蓋胃腸道治療藥物領域。對比沙可啶的需求源自於不同族群的便秘和腸道管理的常見問題，包括老年人和接受導致排便不規律的藥物的患者。其應用包括口服製劑和栓劑製劑，使其能夠靈活應對患者需求和偏好的差​​異。最終用途範圍涵蓋醫院、診所和個人居家照護，推動了強勁的市場需求。影響比沙可啶市場的關鍵成長要素包括與生活方式相關的消化道疾病發病率的增加、胃腸道健康意識的提高以及全球人口老化（這通常需要定期服用瀉藥）。最近的機會包括擴展到新興市場，那裡的醫療保健服務正在改善，並開發創新配方以更快地緩解症狀並減少副作用。利用這些機會的建議包括與醫療保健提供者建立策略夥伴關係以及開展教育宣傳活動，以提高消費者對常規腸道健康的認知。市場成長面臨限制，例如腹部痙攣和腹瀉等潛在副作用、包括自然療法在內的替代療法選擇以及藥物核准和銷售的監管限制。學名藥對定價策略的限制進一步挑戰了競爭格局。透過探索更溫和、更有針對性、副作用最小的配方和擴大預防醫學的使用案例，可以促進創新。數位健康整合，例如監測胃腸健康的應用與比沙可啶的使用相結合，也可以提高患者的依從性和結果。該市場的特點是適度成長和競爭，並受到基本健康需求和瀉藥輸送解決方案創新進步的推動。

主要市場統計
基準年[2023] 12.8億美元
預測年份 [2024] 13.5億美元
預測年份 [2030] 19.9億美元
複合年成長率（%） 6.49%

市場動態：揭示快速發展的比沙可啶市場的關鍵市場洞察

供需的動態交互作用正在改變比沙可啶市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 便秘和神經源性腸功能障礙的盛行率增加
    • 非處方藥的採用增加
  • 市場限制因素
    • 比沙可啶生產原料價格波動
  • 市場機會
    • 持續研究並開發創新製劑和藥物傳遞方法
    • 製造方法的技術進步
  • 市場問題
    • 比沙可啶替代品的可用性

波特的五力：駕馭比沙可啶市場的策略工具

波特的五力框架是了解比沙可啶市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解對比沙可啶市場的外部影響

外部宏觀環境因素在塑造比沙可啶市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解比沙可啶市場的競爭狀況

對比沙可啶市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：比沙可啶市場供應商績效評估

FPNV定位矩陣是評估比沙可啶市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製比沙可啶市場的成功之路

比沙可啶市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 便秘和神經性腸功能障礙的盛行率增加
      • 非處方藥比沙可啶的使用增加
    • 抑制因素
      • 用於生產比沙可啶的原物料價格波動
    • 機會
      • 持續研發創新藥物配方及遞送方法
      • 製造方法的技術進步
    • 任務
      • 比沙可啶替代品的可用性
  • 市場區隔分析
    • 劑量類型：大量採用非處方 (OTC) 口服藥物比沙可啶
    • 用途：提高比沙可啶在便秘和神經源性腸道功能障礙治療的使用率
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章 比沙可啶市場：依管理類型

  • 介紹
  • 口腔醫學
  • 栓劑

第7章 比沙可啶市場：依應用分類

  • 介紹
  • 便秘
  • 神經源性腸功能障礙

第8章比沙可啶市場：按分銷管道

  • 介紹
  • 醫院藥房
  • 網路藥房
  • 零售藥房

第9章 美洲比沙可啶市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太比沙可啶市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲比沙可啶市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 艾伯維向美國FDA 提交額外申請，申請 Linseth（Linaclotide）治療 6 至 17 歲兒童和青少年功能性便秘的新適應症
  • 戰略分析和建議

公司名單

  • Cambrex Corporation
  • Carbogen AMCIS
  • Centurion Remedies Private Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories
  • Enomark
  • Erregierre Spa
  • GlaxoSmithKline plc
  • Joshi Agrochem Pharma
  • Kreative Organics Private Limited
  • Lexicare Pharma Pvt. Ltd.
  • LMG Pharma
  • Mahendra Chemicals
  • Manus Aktteva Biopharma LLP
  • Merck KGaA
  • Sanofi SA
  • Tiefenbacher API+Ingredients GmbH & Co. KG
  • Zuche Pharmaceuticals Pvt. Ltd.
Product Code: MRR-BF5906741E5D

The Bisacodyl Market was valued at USD 1.28 billion in 2023, expected to reach USD 1.35 billion in 2024, and is projected to grow at a CAGR of 6.49%, to USD 1.99 billion by 2030.

Bisacodyl, a stimulant laxative, is primarily used to treat constipation by stimulating bowel movements. In market research, its scope encompasses the pharmaceutical segment of gastrointestinal treatments. The necessity for bisacodyl arises from the prevalent issues of constipation and bowel management in various populations, including the elderly and patients under medication regimens that cause bowel irregularity. Its application spans both oral and suppository forms, making it flexible for different patient needs and preferences. End-use scope extends across hospitals, clinics, and personal at-home care, contributing to its substantial market demand. Key growth factors influencing the bisacodyl market include the increasing incidence of lifestyle-related digestive disorders, growing awareness about gastrointestinal health, and the aging global population, which often requires regular laxative solutions. The latest opportunities highlight the expansion into emerging markets where healthcare access is improving, as well as developing innovative formulations for faster relief and reduced side effects. Recommendations to leverage these opportunities involve strategic partnerships with healthcare providers and educational campaigns to increase consumer awareness about regular bowel health. Nevertheless, market growth faces limitations such as potential side effects like abdominal cramping and diarrhea, alternative treatment options including natural remedies, and regulatory constraints on drug approval and marketing. The competitive landscape is further challenged by generic alternatives, which may restrict pricing strategies. Innovation can thrive through research into gentler, targeted formulations that minimize side effects, as well as expanding use-cases in preventive care. Digital health integrations, such as apps for monitoring digestive health linked with bisacodyl usage, could also enhance patient adherence and outcomes. The market is characterized by moderate growth and competition, driven by fundamental health needs and innovative advancements in laxative delivery solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 1.28 billion
Estimated Year [2024] USD 1.35 billion
Forecast Year [2030] USD 1.99 billion
CAGR (%) 6.49%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bisacodyl Market

The Bisacodyl Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of constipation and neurogenic bowel dysfunction
    • Increasing adoption of over-the-counter bisacodyl drug
  • Market Restraints
    • Volatile prices of raw materials used in manufacturing of bisacodyl
  • Market Opportunities
    • Ongoing research & developments for innovative drug formulation and delivery methods
    • Technological advancements in manufacturing methods
  • Market Challenges
    • Availability of alternative to bisacodyl

Porter's Five Forces: A Strategic Tool for Navigating the Bisacodyl Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bisacodyl Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bisacodyl Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bisacodyl Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bisacodyl Market

A detailed market share analysis in the Bisacodyl Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bisacodyl Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bisacodyl Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bisacodyl Market

A strategic analysis of the Bisacodyl Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bisacodyl Market, highlighting leading vendors and their innovative profiles. These include Cambrex Corporation, Carbogen AMCIS, Centurion Remedies Private Limited, Cipla Limited, Dr. Reddy's Laboratories, Enomark, Erregierre Spa, GlaxoSmithKline plc, Joshi Agrochem Pharma, Kreative Organics Private Limited, Lexicare Pharma Pvt. Ltd., LMG Pharma, Mahendra Chemicals, Manus Aktteva Biopharma LLP, Merck KGaA, Sanofi S.A., Tiefenbacher API + Ingredients GmbH & Co. KG, and Zuche Pharmaceuticals Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Bisacodyl Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Administration Type, market is studied across Oral Medications and Suppository Medications.
  • Based on Application, market is studied across Constipation and Neurogenic Bowl Dysfunction.
  • Based on Distribution Channels, market is studied across Hospital Pharmacy, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of constipation and neurogenic bowel dysfunction
      • 5.1.1.2. Increasing adoption of over-the-counter bisacodyl drug
    • 5.1.2. Restraints
      • 5.1.2.1. Volatile prices of raw materials used in manufacturing of bisacodyl
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research & developments for innovative drug formulation and delivery methods
      • 5.1.3.2. Technological advancements in manufacturing methods
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative to bisacodyl
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Administration Type: Significant adoption of over-the-counter (OTC) oral bisacodyl
    • 5.2.2. Application: Increasing utilization of bisacodyl in managing constipation and neurogenic bowel dysfunction
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bisacodyl Market, by Administration Type

  • 6.1. Introduction
  • 6.2. Oral Medications
  • 6.3. Suppository Medications

7. Bisacodyl Market, by Application

  • 7.1. Introduction
  • 7.2. Constipation
  • 7.3. Neurogenic Bowl Dysfunction

8. Bisacodyl Market, by Distribution Channels

  • 8.1. Introduction
  • 8.2. Hospital Pharmacy
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Bisacodyl Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bisacodyl Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bisacodyl Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. AbbVie Submits Supplemental New Drug Application to U.S. FDA to Support New Indication of LINZESS (linaclotide) for Functional Constipation in Children and Adolescents 6 to 17 Years of Age
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Cambrex Corporation
  • 2. Carbogen AMCIS
  • 3. Centurion Remedies Private Limited
  • 4. Cipla Limited
  • 5. Dr. Reddy's Laboratories
  • 6. Enomark
  • 7. Erregierre Spa
  • 8. GlaxoSmithKline plc
  • 9. Joshi Agrochem Pharma
  • 10. Kreative Organics Private Limited
  • 11. Lexicare Pharma Pvt. Ltd.
  • 12. LMG Pharma
  • 13. Mahendra Chemicals
  • 14. Manus Aktteva Biopharma LLP
  • 15. Merck KGaA
  • 16. Sanofi S.A.
  • 17. Tiefenbacher API + Ingredients GmbH & Co. KG
  • 18. Zuche Pharmaceuticals Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. BISACODYL MARKET RESEARCH PROCESS
  • FIGURE 2. BISACODYL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BISACODYL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BISACODYL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BISACODYL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BISACODYL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BISACODYL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BISACODYL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BISACODYL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BISACODYL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BISACODYL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BISACODYL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BISACODYL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BISACODYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BISACODYL MARKET DYNAMICS
  • TABLE 7. GLOBAL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BISACODYL MARKET SIZE, BY ORAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BISACODYL MARKET SIZE, BY SUPPOSITORY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BISACODYL MARKET SIZE, BY CONSTIPATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BISACODYL MARKET SIZE, BY NEUROGENIC BOWL DYSFUNCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BISACODYL MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BISACODYL MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BISACODYL MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BISACODYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BISACODYL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BISACODYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 144. BISACODYL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. BISACODYL MARKET, FPNV POSITIONING MATRIX, 2023